Our mammalian cell culture capabilities include a strong track record in cell culture development and manufacture. Building on our leadership position in microbial based biopharmaceuticals, we are expanding our cell culture offering with the addition of new technologies and manufacturing assets.
|
As a full service cGMP contract manufacturing organization, we can meet your needs at every stage of the product lifecycle to ensure your product reaches its clinical phase efficiently, rapidly and cost effectively.
|
pAVEway™ is our proprietary and proven technology for the efficient expression of therapeutic proteins. It has recently been improved to permit large-scale protein manufacture using antibiotic-free microbial fermentations.
|
Fujifilm Diosynth Biotechnologies offers fully-flexible state of the art biopharmaceutical facilities for the development of your protein product through all clinical phases, process validation and commercial supply.
|
Home
